Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A
Keyword(s):
2006 ◽
Vol 349
(1)
◽
pp. 255-260
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):